SCHEMBL538370

SCHEMBL538370

OCCCCCCCCCCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.64
MAPT P10636 1/20 0.59
RXFP1 Q9HBX9 1/20 0.59
SIGMAR1 Q99720 9/20 0.58
MAOA P21397 1/20 0.56
LTA4H P09960 1/20 0.55
EPHX2 P34913 1/20 0.55
MAOB P27338 2/20 0.54
HDAC3 O15379 1/20 0.52
MAPK1 P28482 1/20 0.52
ADRA1A P35348 1/20 0.52
HDAC4 P56524 1/20 0.52
SLC6A3 Q01959 1/20 0.52
HDAC1 Q13547 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52
HDAC8 Q9BY41 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL405974 1.00 TDP1 (0.64) TDP1MAPTRXFP1SIGMAR1MAOA
SCHEMBL1006938 1.00 TDP1 (0.64) TDP1MAPTRXFP1SIGMAR1MAOA
SCHEMBL14850009 1.00 TDP1 (0.64) TDP1MAPTRXFP1SIGMAR1MAOA
SCHEMBL1006123 1.00 TDP1 (0.64) TDP1MAPTRXFP1SIGMAR1MAOA
SCHEMBL1006585 1.00 TDP1 (0.64) TDP1MAPTRXFP1SIGMAR1MAOA
SCHEMBL1007046 1.00 TDP1 (0.64) TDP1MAPTRXFP1SIGMAR1MAOA
SCHEMBL1006479 1.00 TDP1 (0.64) TDP1MAPTRXFP1SIGMAR1MAOA
SCHEMBL1005849 1.00 TDP1 (0.64) TDP1MAPTRXFP1SIGMAR1MAOA
SCHEMBL1006372 1.00 TDP1 (0.64) TDP1MAPTRXFP1SIGMAR1MAOA
SCHEMBL95368 1.00 TDP1 (0.64) TDP1MAPTRXFP1SIGMAR1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111344386-A Ester compound, lubricating oil composition containing same, and method for producing same 埃克森美孚化学专利公司 2020-06-26 CN claimed
US-10683464-B2 Ester compounds, lubricating oil compositions containing same and processes for making same EXXONMOBIL CHEMICAL PATENTS INC. (US) 2020-06-16 US claimed
US-20190100711-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same EXXONMOBIL CHEMICAL PATENTS INC. 2019-04-04 US claimed
US-20120226036-A1 SUBSTITUTED CARBONYL COMPOUND UBE INDUSTRIES, LTD. (JP) 2012-09-06 US claimed
EP-2476678-A1 SUBSTITUTED CARBONYL COMPOUNDS Ube Industries, Ltd. (JP) 2012-07-18 EP claimed
EP-0805825-B1 GELS FROM ANHYDRIDE-CONTAINING POLYMERS TYCO ELECTRONICS CORP (US) 2000-08-23 EP claimed
US-5849824-A Gels from anhydride-containing polymers RAYCHEM CORPORATION (US) 1998-12-15 US claimed
EP-0805825-A1 GELS FROM ANHYDRIDE-CONTAINING POLYMERS RAYCHEM CORPORATION (US) 1997-11-12 EP claimed
WO-1996023007-A1 GELS FROM ANHYDRIDE-CONTAINING POLYMERS RAYCHEM CORPORATION (US) 1996-08-01 WO claimed
US-20250011264-A1 CYCLIC COMPOUND AND METHOD FOR PRODUCING CYCLIC COMPOUND SUMITOMO BAKELITE CO., LTD. (JP) 2025-01-09 US disclosed
EP-4434960-A1 CYCLIC COMPOUND AND METHOD FOR PRODUCING CYCLIC COMPOUND Sumitomo Bakelite Co., Ltd. (JP) 2024-09-25 EP disclosed
CN-118265685-A Cyclic compound and method for producing cyclic compound 住友电木株式会社 2024-06-28 CN disclosed
WO-2023176796-A1 SCAR FORMATION INHIBITOR, FIBROBLAST PROLIFERATION INHIBITOR, AND METHOD FOR PRODUCING NANOPARTICLES 国立大学法人東北大学 2023-09-21 WO disclosed
WO-2023090298-A1 CYCLIC COMPOUND AND METHOD FOR PRODUCING CYCLIC COMPOUND 住友ベークライト株式会社 2023-05-25 WO disclosed
US-4834909-A Thermochromic double-complex salts MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-05-30 US disclosed
US-4826774-A MONITORING MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-05-02 US disclosed
US-4810401-A Superparamagnetic solid particles BASF AKTIENGESELLSCHAFT (DE) 1989-03-07 US disclosed
EP-0277032-A2 Thermochromic double-complex salts MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1988-08-03 EP disclosed
EP-0277033-A2 Article and Method for Vapochromic Monitoring, utilising transition - metal double complex salts MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1988-08-03 EP disclosed
US-4524059-A Fatty acid analogs THE GENERAL HOSPITAL CORPORATION (US) 1985-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120226036-A1 SUBSTITUTED CARBONYL COMPOUND PTGER2, PTGER1, LTB4R2 TDP1 4750/4885MAPT 4683/4885RXFP1 317/4885
US-20190100711-A1 Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same ELOVL1, ELOVL5, ELOVL3 TDP1 1206/4885MAPT 2295/4885RXFP1 4710/4885
US-10683464-B2 Ester compounds, lubricating oil compositions containing same and processes for making same ELOVL1, ELOVL5, ELOVL3 TDP1 1206/4885MAPT 2295/4885RXFP1 4710/4885
US-20250011264-A1 CYCLIC COMPOUND AND METHOD FOR PRODUCING CYCLIC COMPOUND CA1, ASIC1, CA7 TDP1 4836/4885MAPT 4590/4885RXFP1 4670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.